FDA Approval for Trabectedin. Use in Cancer. Trabectedin is approved to treat: Liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have metastasized (spread to other parts of the body). It is used in patients who have already been treated with anthracycline chemotherapy. Trabectedin is also being studied in the treatment of other types of cancer. More About Trabectedin. Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. MedlinePlus Information on Trabectedin - A lay language summary of important information about this drug that may include the following: warnings about this drug, what this drug is used for and how it is used,
Blood Clots in Urine. Blood clots in urine can be a sign of an internal injury that causes bleeding, inflammation, or disease. The medical term used for blood in the urine is hematuria. Blood clots in urine obviously result from large enough bleeding to turn the color of urine red and have visible clots. Visible presence of blood in urine is called gross hematuria. Some of the most common causes of blood clots in urine are kidney diseases or other urinary tract problems.
blood in urine causes infection blood in the urine can be a sign of urinary tract infection uti nephrolithiasis kidney or bladder stones may form inside the urinary tract and can cause bleeding into the urine kidney disease diseases of the kidney can be associated with blood in the urine prostate gland enlargement enlargement of the cnjury trauma to the urinary tract can cause bleeding into the urine drugs medications including aspirin heparin and penicillin can cause hematuria strenuous exercise although the reasons are poorly understood strenuous exercise has been associated with blood in the urine